Sharon L. Hirsch, MD

Education & Training

• M.D. 1986, The University of Texas Medical Branch (UTMB)
• PGY-I (General Psychiatry Internship) 1986-1987, UTMB
• PGY-II/III (Adult Psychiatry), 1987-1989, The University of California, San Diego (UCSD)
• PGY-IV/V (Adult Psychiatry/ Neuropsychopharmacology NIH Research Fellow) 1989-1991, UCSD
• PGY VI-VIII (Child Psychiatry/ Child Psychopathology NIH Research Fellow), 1991-1994, The University of California, Los Angeles (UCLA)
• 1992, American Board of Psychiatry and Neurology (Psychiatry)
• 1995 American Board of Psychiatry and Neurology (Child and Adolescent Psychiatry), Renewed 5/2005

Clinical Interests

• Mood and anxiety disorders, including trauma
• Autism related neurodevelopmental disorders, including genetic disorders
• Attention Deficit Hyperactivity Disorder and related disorders
• Neuropsychopharmacology

Research Interests

• Psychiatric phenotypes of genetic disorders
• Neurobiology of inattention and impulsivity
• Clinical psychopharmacology of mood, anxiety and trauma
• Neuroanatomic and genetic underpinnings of developmental disorders

Teaching

• Director, Advanced Pediatric Psychopharmacology
• Director, Pediatric Psychopathology (PGY-II)
• Director, School Consultation Program
• Medical Director, Trauma Team
• Co-director, Pediatric Systems of Care
• Pediatric Psychiatry, Clerkship lectures

Society Memberships

• American Academy of Child and Adolescent Psychiatry
• American Academy of Clinical Psychiatrists
• Illinois Council of Child and Adolescent Psychiatry Executive Board Member and Representative to the National Assembly
• American Medical Association

Selected Publications

• Coccaro EF, Hirsch SL, Stein MA. Plasma homovanillic acid correlates inversely with history of learning problems in healthy volunteer and personality disordered subjects.  Psychiatric Research 2007 Jan 15; 149(1-3): 297-302
• Hirsch, S and Sheffield, R.  Clinical case: Coping with a child’s conduct disorder (Commentary). Virtual Mentor: American Medical Association Journal of Ethics 2006 October; 8 (10):  654-658
• Quinn D., Wigal S., Swanson J., Hirsch S., Ottolini Y., Dariani M., Roffman M., Zeldis J., Cooper T. Comparative pharmacodynamics and plasma concentrations of d-threo-methylphenidate hydrochloride after single doses of d-threo-methylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in a double-blind, placebo-controlled, crossover laboratory school study in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2004 Nov; 43(11):1422-9
• Sharon L. Hirsch, MD.  The Doctor is in- when is being “hyper” more than just an Attention Deficit Hyperactivity Disorder?  The Child’s Doctor Journal of Children’s Memorial Hospital Chicago Spring 1998
• Mirow AL, Kristbjanarson H, Egeland JA, Shilling P, Helgason T, Gillin JC, Hirsch S, Kelsoe JR. A linkage study of distal chromosome 5q and bipolar disorder. Biological Psychiatry 1994 Aug15;36(4): 223-9
• Kelsoe JR, Kristbjanarson H, Bergesch P, Shilling P, Hirsch S, Mirow A, Moises HW, Helgason T, Gillin JC, Egeland JA: A Genetic linkage study of bipolar disorder and 13 markers on chromosome 11 including the D2 dopamine receptor. Neuropsychopharmacology 1993 Dec; 9(4): 293-301
• Gillin JC, Sutton L, Ruiz C, Golshan S, Hirsch S, Warmann C, Shiromani P: Dose dependent inhibition of REM sleep in normal volunteers by biperiden, a muscarinic antagonist. Biological Psychiatry 1991 Jul 15; 30(2): 151-6
• August GJ, Raz N, Pappanicolaou AC, Baird TD, Hirsh SL, Hsu LL: Fenfluramine Treatment in Infantile Autism: Neurochemical, Electrophysiological, and Behavioral Effects. Journal of Nervous and Mental Disease 1985; 172(10): 604-12

Selected Conferences & Presentations

• Declan Quinn, James M. Swanson, Sharon L Hirsch:  Pharmacokinetics, Pharmacodynamics and Safety of Dexmethylphenidate HCL (Focalin) and Racemic Methylphenidate.  Presented at the 49th Annual Meeting of the American Academy of Child and Adolescent Psychiatry Meeting, San Francisco, 2002
• Speaker – Psychiatric Manifestations of Genetic Illness.  University of California Los Angeles Division of Medical Genetics Journal Club, Los Angeles, CA 1992
• Speaker – Treatment of the Patient with PTSD, Belmar Child Guidance Clinic, Annual Conference, Los Angeles, CA, 1993
• Speaker – The Current Political Climate for Treatment for Psychiatry.  Grand Rounds, Child and Adolescent Psychiatry, University of Los Angeles, Co-presenters, Drs. Mary Jane England and Peter Tanguay, Los Angeles, CA, 1993
• Featured Speaker – Fragile X: Pediatric Grand Rounds.  Children’s Memorial Hospital, Chicago, IL, 1994
• Featured Speaker – Psychiatric Aspects of Genetic Illness: Fragile X and Other Syndromes.  Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, IL, 1995
• Featured Speaker – Conduct and Behavioral Problems in Children, Pediatric Grand Rounds, Northwest Community Hospital, Chicago, IL, 1996
• Featured Speaker – Developmental Psychopharmacology.  Asher Basic and Clinical Sciences Seminar, Northwestern University, Chicago, IL, 1996
• Speaker – Psychopharmacology Update: Chicago Medical Society Midwest Clinical Conference, Chicago, IL, 2000
• Speaker – Attention Deficit Hyperactivity Disorder.  AACAP 26th Annual Review Course, Chicago, IL, 2000
• Featured Speaker – Are Your Genes Blue? Diagnosis and Treatment of Genetic Disorders in Psychiatry.  Warren Wright Presentation, Child Psychiatry Grand Rounds, Chicago, IL, 2001
• Speaker – ADHD: Treatment Across the Ages.  Psychiatric Update/ Fall 2003 - Admonitions and Affirmations from Accomplished and Articulate Academicians at The University of Wisconsin Madison Medical School, Fall 2003
• Speaker – Coping with Distraction: A Focus on ADHD.  Centegra Spring Clinical Symposium on Behavioral Health, 2004
• Featured Speaker – Anxiety and Depression in Children.  Grand Rounds, Norwegian American Hospital, 2005
• Featured Speaker – In the Pits: The Myths, Symptoms and Treatment of Childhood Depression.  Annual CME Event, MacNeal Hospital, 2006
• Speaker – Controversies in Prescribing Psychiatric Medications to Children and Adolescents.  AMSA Annual Meeting, 2006
• Speaker- Depression in Children and Adolescents.  Centegra Spring Clinical Symposium on Behavioral Health, March 2009
• Speaker- Psychological Aspects of IBD in Children and Adolescents. Illinois CCFA Annual Meeting, April 4, 2009

Other Activities

• Department of Psychiatry and Behavioral Neuroscience, Management Committee
• Department of Psychiatry and Behavioral Neuroscience Quality Assurance Committee member
• Medical director, Trauma Team
• Phoenix Electronic Medical Record Development Group, Department of Psychiatry and Behavioral Neuroscience and Department of Pediatrics